Phenotypic differences in nebivolol metabolism and bioavailability in healthy volunteers

INTRODUCTION: Nebivolol, a third-generation β-blocker, is subject to extensive first-pass metabolism and produces active β-blocking hydroxylated metabolites, like 4-OH-nebivolol. It is primarily a substrate of CYP2D6, a metabolic pathway that is under polymorphic genetic regulation. The objective of...

Descripción completa

Detalles Bibliográficos
Autores principales: BRICIU, CORINA, NEAG, MARIA, MUNTEAN, DANA, BOCSAN, CORINA, BUZOIANU, ANCA, ANTONESCU, OANA, GHELDIU, ANA-MARIA, ACHIM, MARCELA, POPA, ADINA, VLASE, LAURIAN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iuliu Hatieganu University of Medicine and Pharmacy 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4576779/
https://www.ncbi.nlm.nih.gov/pubmed/26528073
http://dx.doi.org/10.15386/cjmed-395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4576779/
https://www.ncbi.nlm.nih.gov/pubmed/26528073
http://dx.doi.org/10.15386/cjmed-395

Ejemplares similares